Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ryan Hays has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Responsive Neurostimulation in Patients with a History of Viral Brain Infections—A Single-Center Experience

    by Melissa Huynh Mabry, Irina Podkorytova, Ebenezer Chinedu-Eneh, Sasha Alick-Lindstrom, Kan Ding, Ryan Hays, Ghazala Perven

    Drug-resistant epilepsy (DRE) secondary to viral brain infections (VBI) may have multiple seizure foci, making it not amenable to surgical resection but could respond to responsive neurostimulation (RNS). We aimed to evaluate characteristics of DRE patients with a VBI history who did or did not respond to RNS therapy; 9 patients met criteria. Four out of 9 patients were responders to RNS therapy with ≥50% of seizure-frequency reduction at an average 39-month follow-up. Five patients were non-responders, an average 47-month follow-up. Two responders had a prior destructive surgery. Four non-responders had a prior neurosurgery including 1 focal resection, 2 vagus nerve stimulation, and 1 prior RNS. Patients in the responder group had shorter DRE duration prior to RNS placement than in the non-responder group (average 11.0 years versus 14.4 years). Three responders and four non-responders had a history of focal to bilateral tonic–clonic seizures (FBTC) pre-RNS. Post-RNS, all responders and 2 non-responders stopped experiencing FBTC. Our study demonstrates that RNS therapy could be effective in patients with DRE secondary to VBI, even if the patients failed previous surgical intervention(s). Patients in both responder and non-responder groups had reduction of convulsive seizures. These findings should be considered preliminary observations due to a small sample-size.


  • Open Access

    Prevalence of Temporal Lobe Epilepsy (TLE) Subtypes and Response to Resective Surgery in Patients with Presumed TLE Undergoing Limbic and Paralimbic Network Exploration with Stereo-Electrodes

    by Irina Podkorytova, Sasha Alick-Lindstrom, Kan Ding, Ryan Hays, Ghazala Perven

    Background/Objectives: Temporal lobe epilepsy (TLE) responds well to surgical treatment, although a considerable percentage of patients experience seizure recurrence after resection. Relapse from the contralateral mesial temporal lobe, extratemporal lobe epilepsy mimicking TLE, or temporal plus epilepsy might account for surgical failures. Methods: We included patients with a pre-implantation hypothesis suggesting TLE, who underwent stereo-EEG (SEEG) evaluation at our institution and had an individual SEEG exploration paradigm with at least twelve stereo-electrodes placed to sixteen brain regions allowing exploration of limbic and paralimbic networks. We analyzed the prevalence of TLE subtypes based on ictal onset localization with SEEG and response to resective surgery. Results: Twenty-four subjects met the inclusion criteria. Seven patients had unilateral mesial temporal epilepsy (UMTE), five had bilateral mesial temporal epilepsy (BMTE), five had unilateral neocortical temporal epilepsy (UNTE), six had temporal-plus epilepsy (TPE), one had extratemporal epilepsy (ETE). The number of patients who underwent destructive surgeries and surgical outcomes are as follows: UMTE—all seven patients, Engel I; BMTE- three out of five, Engel I, III, and IV, respectively; UNTE—three out of five, Engel I; TLE mimic (ETE)—one, Engel I; TPE—all six patients, Engel I–three, Engel III–two, Engel IV—one. Conclusions: In our study, UMTE was the most frequent TLE subtype (29%), and all patients proceeded to resective surgery with good outcomes. TPE comprised a substantial component (25%) of this cohort with initially presumed TLE, who had a notable proportion of unfavorable outcomes. Larger studies are needed to create guidelines for rational counseling of patients with presumed TLE regarding surgical outcomes.


  • Open Access

    Stereo-electroencephalographic seizure localization in patients with mesial temporal sclerosis: A single center experience

    by Bill Zhang, Irina Podkorytova, Ryan Hays, Ghazala Perven, Mark Agostini, Jay Harvey, Rodrigo Zepeda, Sasha Alick-Lindstrom, Marisara Dieppa, Alex Doyle, et al.


  • Real-Time Seizure Detection Using Behind-the-Ear Wearable System

    by Jamie Lehnen, Pooja Venkatesh, Zhuoran Yao, Abdul Aziz, Phuc V.P. Nguyen, Jay Harvey, Sasha Alick-Lindstrom, Alex Doyle, Irina Podkorytova, Ghazala Perven, et al.

    Introduction: This study examines the usability and comfort of a behind-the-ear seizure detection device called brain seizure detection (BrainSD) that captures ictal electroencephalogram (EEG) data using four scalp electrodes. Methods: This is a feasibility study. Thirty-two patients admitted to a level 4 Epilepsy Monitoring Unit were enrolled. The subjects wore BrainSD and the standard 21-channel video-EEG simultaneously. Epileptologists analyzed the EEG signals collected by BrainSD and validated it using video-EEG data to confirm its accuracy. A poststudy survey was completed by each participant to evaluate the comfort and usability of the device. In addition, a focus group of UT Southwestern epileptologists was held to discuss the features they would like to see in a home EEG-based seizure detection device such as BrainSD. Results: In total, BrainSD captured 11 of the 14 seizures that occurred while the device was being worn. All 11 seizures captured on BrainSD had focal onset, with three becoming bilateral tonic-clonic and one seizure being of subclinical status. The device was worn for an average of 41 hours. The poststudy survey showed that most users found the device comfortable, easy-to-use, and stated they would be interested in using BrainSD. Epileptologists in the focus group expressed a similar interest in BrainSD. Conclusions: Brain seizure detection is able to detect EEG signals using four behind-the-ear electrodes. Its comfort, ease-of-use, and ability to detect numerous types of seizures make BrainSD an acceptable at-home EEG detection device from both the patient and provider perspective.


  • Thalamic neuromodulation outcomes in drug-resistant refractory epilepsy with Deep Brain Stimulation and Responsive Neurostimulation (P5-1.003)

    by Rohit Das, Irina Podkorytova, Chijindu Iheanacho, Sasha Alick-Lindstrom, Mark Agostini, Alexander Doyle, Kan Ding, Ryan Hays, Ghazala Perven, Marisara Dieppa, et al.

    Objective: We aim to compare effects of thalamic Deep Brain Stimulator (DBS) and responsive neurostimulator (RNS) device therapy on seizure burden in drug-resistant epilepsy patients. Background: Intractable epilepsy unamenable to cortical resection is often treated with a device, either RNS or DBS provides intracranial stimulation. The devices are thought to reduce seizure frequency by reducing synchronization of cortical activity. The RNS provides more localized stimulation while the DBS does this by stimulating the anterior nucleus of the thalamus. At our institution a small number of patients have also undergone thalamic stimulation by using the RNS. Design/Methods: We performed retrospective analysis on seizure frequency pre-implant and at most recent follow-up for our cohort, 12 DBS and 6 RNS patients. Results: Average age of RNS implantation was 30 years (range 19–41) vs 42 years (range 18–66) for DBS. Thirteen (9 DBS, 4 RNS) of the 18 patients had stereo-EEG (SEEG) evaluation before device placement, SEEG ictal onset was broad or multifocal in all (DBS: 7 – bilateral and 2 – unilateral, RNS: 3 bilateral, 1 unilateral). Three out of five patients who did not have invasive EEG evaluation before device placement had suspected (2) or confirmed (1) genetic etiology, all five had non-localizing, non-lateralizing scalp ictal EEG. The electrodes were placed to the anterior nucleus of thalamus bilaterally in all DBS and four RNS patients, two RNS patients had centromedian nucleus of thalamus sampling. Twelve of our 18 patients (8 out of 12 DBS and 4 out of 6 RNS) were shown to be responders, achieving 50% or greater reduction in seizure frequency. The average follow-up duration for RNS was 22 months (range 3–36), for DBS 13.5 months (range 2–29). Conclusions: This analysis demonstrates the potency of thalamic neuromodulation, both RNS and DBS, as therapies capable of seizure relief in wide breadths of epilepsy presentations. Disclosure: Dr. Das has received personal compensation for serving as an employee of Concentra. Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH. irina podkorytova has nothing to disclose. Chijindu Iheanacho has nothing to disclose. Dr. Alick-Lindstrom has nothing to disclose. Dr. Agostini has nothing to disclose. Dr. Doyle has nothing to disclose. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Hays has nothing to disclose. Dr. Perven has nothing to disclose. Dr. Dieppa has nothing to disclose. Dr. Zepeda Garcia has nothing to disclose.

  • Efficacy and Quality of Life Outcome of Combined Epilepsy Surgery with RNS Placement (P5-1.002)

    by Jie Pan, Shazia Mirza, Mark Agostini, Sasha Alick-Lindstrom, Rohit Das, Kan Ding, Alexander Doyle, Marisara Dieppa, Ryan Hays, Jay Harvey, et al.

    Objective: Retrospectively review clinical outcomes in patients treated with resection or Laser interstitial Thermal Therapy (LiTT) immediately (≤ 90 days) after implantation of RNS. Background: Surgical resection and LiTT are standard treatments for refractory epilepsy, but these options can be limited by eloquent cortex and seizure multifocality. Previous studies have suggested RNS may be used in conjunction with resective surgery (RNS+R) or LiTT (RNS+LiTT) as a new combination of treatments. Besides seizure control, quality of life and psychiatric symptoms including depression and anxiety are considered as important outcome evaluation after epilepsy surgery. Design/Methods: 34 patients that had RNS+R or RNS+LiTT at our center were reviewed and 10 were excluded. The decision of dual procedures was made prior to surgery. Patients received RNS+R had both resective surgery and RNS placement in the same procedure. Patients received RNS+LiTT had several weeks gap between the RNS placement and LiTT due to neurosurgical logistics. Clinical follow-ups were performed at 12, 18, 24, 36 and 48 months for evaluation of seizure frequency. Patient health questionnaire-9 (PHQ-9) is used as a depression assessment. Quality of life in epilepsy questionnaire (QOLIE-31) was used as scoring for evaluation of general quality of life. Results: Among the 24 patients that had RNS+R or RNS+LiTT, 22 patients (91.6%) showed improved seizure frequency at the last follow up. Fourteen patients had PHQ-9 evaluation and the average score was 5.85±6.29 (mean±SD), among which nine were between 0–4 (minimal depression), one was between 5–9(mild depression), three were between 10–14(moderate depression), one was 15–19(moderately severe depression) and none was 20–27(severe depression). QOLIE-31 done in eight patients showed average score of 65.61 ± 18.09 (mean±SD) in last follow-up visit. Conclusions: Our study showed significant seizure control rate of RNS+R or RNS+LiTT therapy in refractory epilepsy patients. It also suggestive for promising psychiatric outcomes and quality of life scoring after surgery. Disclosure: Dr. Pan has nothing to disclose. Dr. Mirza has nothing to disclose. Dr. Agostini has nothing to disclose. Dr. Alick-Lindstrom has nothing to disclose. Dr. Das has received personal compensation for serving as an employee of Concentra. Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Doyle has nothing to disclose. Dr. Dieppa has nothing to disclose. Dr. Hays has nothing to disclose. Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals. The institution of Bradley Lega has received research support from NIH. irina podkorytova has nothing to disclose. Dr. Zepeda Garcia has nothing to disclose. Dr. Perven has nothing to disclose.

  • EEG abnormalities in patients with PNES (P1-1.003)

    by Shazia Mirza, Mark Agostini, Kan Ding, Alexander Doyle, Sasha Alick-Lindstrom, Irina Podkorytova, Ryan Hays, Rodrigo Zepeda Garcia, Ghazala Perven, Marisara Dieppa, et al.

    Objective: Our goal is to characterize EEG abnormalities in patients with psychogenic non epileptic seizures (PNES) with and without epilepsy as well as examine the relationship between EEG and imaging in this cohort at a Level-4 Epilepsy center. Background: Prior studies have shown that PNES patients have higher rates of EEG abnormalities; both epileptiform and non-epileptiform as compared to the general population. Studies have noted EEG changes in patients with PNES. For most of these studies, studying EEG abnormalities were not a primary goal. These studies were older, had smaller sample sizes, some were in specific groups (children, neurological conditions, developmentally delayed people ) or did not distinguish between underlying cerebral disorders vs or epilepsy. In one recent larger study, which did find higher rate of interictal EEG abnormalities in patients with PNES (1.8 times more likely, this did not reach significance) but used routine EEGs to study interictal data. Design/Methods: Retrospective chart review of all patients discharged from the Epilepsy Monitoring Unit between 1/2016 and 12/2018. Results: 287 patients with PNES and 17 with PNES and epilepsy (PNES+E) were included. Age was mean of 41 years (PNES) and 39 years (PNES+E). 78.4% of PNES patients had normal interictal EEG, 21.6% had abnormal interictal EEG. 17.6% of PNES+E patients had normal interictal EEG and 82.4% had abnormal interictal EEG. Overall, 15.1 % of patients had an interictal epileptiform abnormality. 10.8% of pts with PNES had epileptiform discharges as compared to 88.2% of patients with PNES+E. Overall, 17.4% of the total pts had a non-epileptiform abnormality on their EEG. In the PNES group, this was 16% and in the PNES+E group, it was 41.2% Conclusions: Patients with PNES have a much higher rate of epileptiform discharges at 11% compared to the general population (~2%) Disclosure: Dr. Mirza has nothing to disclose. Dr. Agostini has nothing to disclose. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Doyle has nothing to disclose. Dr. Alick-Lindstrom has nothing to disclose. irina podkorytova has nothing to disclose. Dr. Hays has nothing to disclose. Dr. Zepeda Garcia has nothing to disclose. Dr. Perven has nothing to disclose. Dr. Dieppa has nothing to disclose. Dr. Das has received personal compensation for serving as an employee of Concentra. Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH.

  • Open Access

    Education Research: Enhancing Medical Student Interest in Careers in the Clinical Neurosciences Through a Hands-on Procedure Workshop

    by Collin Sanderson, Khadijah Mazhar, Mark P. Goldberg, Shilpa Chitnis, Ryan Hays, Hina Dave

    Objectives: The knee joint is the most common site for injury among younger people, the injury often resulting in expensive (surgical) treatment, long-term rehabilitation and permanent functional impairment and disability. Methods: We investigated the incidence and risk factors for a major knee-ligament injury in an adolescent Finnish population. A population-based cohort of 46 472 adolescents was followed for an average of 9 years. All patients hospitalised with the diagnosis of anterior or posterior cruciate ligament injury (ACL or PCL injury) were included in the analysis. Results: 265 (0.6%) people (194 male and 71 female subjects) from the total cohort of 46 472 were treated for a cruciate ligament injury of the knee during the follow-up period, giving an injury incidence of 60.9 (95% CI 53.6 to 68.2) per 100 000 person-years. When the socioeconomic, health and lifestyle background variables were taken into account, the adjusted hazard ratio for a cruciate ligament injury of the knee was 8.5 (95% CI 4.3 to 16.4) for female and 4.0 (95% CI 2.7 to 6.1) for male subjects who participated in organised sports ⩾4 times/week. Conclusions: The general risk for a cruciate ligament injury of the knee is relatively low among adolescents and young adults, but participation in organised sports increases the risk significantly. The risk is especially high in active young women. Preventive measures should be adopted to decrease the short-term and long-term burden of these severe injuries.


  • Open Access

    Epilepsy surgery in patient with monogenic epilepsy related to SCN8A mutation

    by Irina Podkorytova, Ryan Hays, Ghazala Perven, Sasha Alick Lindstrom


  • Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital

    by Swetha Ramamurthy, L. Steven Brown, Mark Agostini, Sasha Alick Lindstorm, Hina Dave, Marisara Dieppa, Kan Ding, Alexander Doyle, Ryan Hays, Jay Harvey, et al.